Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
147 items

Stanford Medicine researchers build an eye ‘aging clock’ that could lead to treatments for ocular diseases

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.
Ruchi Sharma

National Eye Institute researcher receives Knights Templar Eye Foundation award for advancing albinism research

Ruchi Sharma, Ph.D., a staff scientist in the NEI Ocular and Stem Cell Translational Section, received an award from the Knights Templar Eye Foundation (KTEF), a charity sponsored by the Grand Encampment of Knights Templar.

New gene-editing technique holds potential for treating childhood blindness

Using a new experimental technique to fix faulty eye cells, a team led by University of Wisconsin researchers was able to repair a gene mutation that causes one form of childhood blindness.

NEI grantees receive Lasker Award for imaging discovery

The Lasker Foundation cited a trio of scientists, who with NEI funding, developed OCT, one of the most widely used technologies for imaging the eye.
Fundus photo showing medium drusen

LSU Health New Orleans researchers discover a key failure in AMD that may lead to progression and vision loss

Research suggests that age-related macular degeneration (AMD) decreases an essential fatty acid, preventing the formation of a class of protective molecules and reducing repair potential.
Two boys smile at the camera. Asymmetric dark spots block parts of the image, representing vision loss from diabetic retinopathy.

MSU researchers discover link between cholesterol and diabetic retinopathy

Researchers found that diabetes, age-related health conditions and other metabolic disorders can lead to a buildup of cholesterol in the retina, which could contribute to diabetic retinopathy.
New York subway with moving train.

New app developed at NYU Tandon promises to make navigating subway stations easier for people with blindness and low vision

Designed by researchers at NYU, Commute Booster routes public-transportation users through the “middle mile” — the part of a journey inside subway stations or other similar transit hubs.
Schematic shows blood vessel leakage on side of retina

Could drops replace eye injections for retina disease?

A new study suggests that eye drops developed by Columbia University researchers could be a more effective–and comfortable–therapy for a common eye disease currently treated with injections into the eye.
Artistic rendering of retinal blood vessels with blood vessel damage.

Experimental drug inhibits or prevents diabetic eye disease in Wilmer Eye Institute study

Researchers from Johns Hopkins Medicine show that experimental drug may prevent or slow vision loss in people with diabetic retinopathy, a complication of diabetes.
Schematic showing SREDs bind to G-protein coupled receptors to promote cell survival

UCI researchers discover new drugs with potential for treating world’s leading causes of blindness

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).